Skip to main content

Chanakya

Login

Injecto Polymers IPO

Published: 8 September 2026 | 6.00 AM
Last Updated: 8 September 2026 | 6.00 AM

Injecto Polymers IPO Snapshot

Particulars Details
Chanakya View 🟡 Selective Apply
Overall Rating ⭐⭐⭐☆☆ (3.5/5)
GMP Today Updated Daily
Issue Size Rs. 56.12 crore
Fresh Issue 56.12 lakh shares
Price Band Rs. 90–Rs. 100
Lot Size 1,200 shares
Minimum Retail Investment Rs. 2,40,000 for 2,400 shares
IPO Opens 11 September 2026
IPO Closes 16 September 2026
Allotment 17 September 2026
Listing 21 September 2026
Exchange BSE SME
Market Capitalisation Rs. 207.90 crore
Market Maker Reservation 2,83,200 shares
Market Maker Not stated in supplied data
Company Address Poddar Court, 18 Rabindra Sarani, Kolkata, West Bengal – 700001
Lead Manager Indcap Advisors Pvt. Ltd.
Registrar Integrated Registry Management Services Pvt. Ltd.

Investor Decision Box

Question Chanakya View
Suitable for Listing Gain? 🟡 Depends on GMP and subscription
Suitable for Long-Term? 🟡 Selective
Risk Level High
Business Quality ⭐⭐⭐⭐☆
Financial Growth ⭐⭐⭐⭐☆
Balance Sheet ⭐⭐☆☆☆
Valuation Comfort ⭐⭐⭐☆☆

👉 | IPO GMP|IPO Reviews |IPO Subscription|IPO Allotment

Chanakya View

Injecto Polymers Limited operates an established packaging-products business with more than two decades of experience. Its diversified portfolio, customised B2B solutions, multiple quality certifications and exposure to agriculture, food, pharmaceuticals, chemicals, construction and consumer-goods industries provide business stability.

Financial performance improved sharply during FY2025. Total income increased to Rs. 261.85 crore from Rs. 109.80 crore in FY2024, while profit after tax rose to Rs. 8.11 crore from Rs. 4.44 crore. EBITDA also advanced to Rs. 22.57 crore. The improving PAT and EBITDA margins strengthen the investment case.

However, borrowings of Rs. 101.11 crore remain a major concern relative to net worth of Rs. 47.33 crore. Although Rs. 12.60 crore from the IPO proceeds will be used to repay borrowings, investors must monitor leverage and finance costs.

The post-issue P/E ratio of 25.64 times is not inexpensive for an SME packaging company. Therefore, the final investment decision should depend on GMP, subscription demand and broader SME-market sentiment.

Chanakya Recommendation: 🟡 Selective Apply

About Injecto Polymers Limited

Incorporated in 1998, Injecto Polymers manufactures packaging products and trades in plastic granules and PVC resins. Its product portfolio includes polypropylene woven fabrics and bags, BOPP bags, Leno bags, LD and polyester pouches, FIBC bags and non-woven bags.

The company follows a B2B model and provides customised packaging products in multiple sizes and specifications. Its customers operate across agriculture, food, pharmaceuticals, textiles, chemicals, construction and consumer-goods sectors.

Injecto Polymers operates two manufacturing units in West Bengal. Unit I is situated at Jaugram, Jamalpur, while Unit II is located in Howrah. It maintains in-house testing facilities and holds ISO 9001:2015, ISO 22000:2018 and BIS certification for food-grade packaging.

Why This IPO Stands Out

✅ Operating history extending back to 1998.

✅ Diversified packaging portfolio serving several industries.

✅ Total income increased by approximately 138% in FY2025.

✅ Profit after tax rose by approximately 83% to Rs. 8.11 crore.

✅ Rs. 29.29 crore will fund Phase IV expansion at Unit I.

✅ Part of the proceeds will reduce outstanding borrowings.

✅ ROE improved to 28.94%, while RoNW reached 25.28%.

✅ Quality certifications and in-house testing support product credibility.

The key risks are high borrowings, raw-material price volatility, modest PAT margins and a post-issue valuation that already factors in meaningful growth. Investors should verify current GMP and subscription trends before committing funds.

IPO Proceeds and Why They Matter

PurposeAmount
Phase IV expansion at Unit IRs. 29.29 crore
Repayment or prepayment of borrowingsRs. 12.60 crore
General corporate purposesBalance amount

The largest allocation will fund Phase IV expansion at the company’s Jaugram manufacturing facility. This could improve production capacity and support future revenue growth. Debt repayment should reduce finance costs, although borrowings will remain an important factor to monitor.

Business Outlook

Demand for flexible and industrial packaging is supported by agriculture, food, pharmaceuticals, textiles, chemicals, construction and consumer goods. Injecto Polymers benefits from a diversified product portfolio and customised B2B packaging solutions.

The proposed capacity expansion provides a visible growth trigger. However, profitability remains sensitive to polymer and resin prices. Sustaining margins while expanding production will determine whether the company can justify its post-issue valuation.

Strengths vs Concerns

👍 Strengths⚠ Concerns
Operating history since 1998Borrowings of Rs. 101.11 crore
Diversified packaging productsPost-issue P/E of 25.64 times
Strong FY2025 revenue growthPAT margin remains modest
Expansion-led use of proceedsVolatile polymer prices
Multiple quality certificationsSME liquidity risk

Who Should Apply?

Investor TypeSuitability
Listing-Gain Investors⭐⭐⭐☆☆
Long-Term Investors⭐⭐⭐☆☆
Conservative Investors⭐⭐☆☆☆
High-Risk Investors⭐⭐⭐⭐☆

Listing-gain investors should apply only if GMP and subscription demand remain healthy. Long-term investors comfortable with SME risk may consider a limited allocation because the expansion project could support future growth.

Chanakya Final Verdict

Injecto Polymers has an established packaging business, diversified customers and sharply improving financial performance. The use of IPO proceeds for capacity expansion and debt repayment is positive. However, borrowings remain high, margins are modest and the post-issue P/E of 25.64 times leaves limited room for operational disappointment. The issue is better suited to investors with a high risk appetite. Listing-gain applicants should monitor GMP and subscription demand before applying.

Chanakya Recommendation: 🟡 Selective Apply | Rating: 3.5/5

Frequently Asked Questions

Should investors apply for the Injecto Polymers IPO?

Investors may apply selectively if GMP and subscription trends remain supportive. Conservative investors should avoid aggressive exposure.

What is the Injecto Polymers IPO price band?

The price band is Rs. 90–Rs. 100 per share, with a minimum individual investment of Rs. 2,40,000.

How will Injecto Polymers use the IPO proceeds?

The company will primarily fund manufacturing expansion, repay certain borrowings and meet general corporate requirements.

Injecto Polymers IPO Summary

Leave a Reply

Your email address will not be published. Required fields are marked *